Replies to post #237122 on Biotech Values

[DewDiligence]

I just started a Twitter thread on the subject of Matt's blog:

I fully concur wrt $ISEE's weak dataset. Re dry—>wet conversion: My disagreement is with the way you seek to marginalize wet AMD by stating that it’s “treatable” with existing meds. Yes,wet AMD is treatable,but in vast majority of cases,the treatments fail to restore good vision.

— Roy Friedman (@DewDiligence) February 15, 2021

Thanks for bringing this Twitter poster to my attention—I should have been following him all along.